Skip to content
Stay curious ↗

Follow your curiosity.

Try “brain”, “genomics”, or another subject you follow.

Today/Drug Development
Drug Development · The big question

Activating support cells helps the brain clear Alzheimer's in mice

Boosting one protein helps the brain fight Alzheimer’s

Science Daily1 min readAI-assisted summary
Editorial illustration for Boosting one protein helps the brain fight Alzheimer’s
Editorial illustration

Summary

Researchers have discovered a clever new way to fight Alzheimer's disease by turning to the brain's own natural defense system. The condition is known for leaving harmful plaques scattered throughout the brain. Now, scientists have found that they can help the brain clear away this toxic buildup by activating its native support network.

The heroes of this story are astrocytes, which are star-shaped cells dedicated to maintaining general brain health. The research team figured out that by increasing the levels of a specific protein called Sox9, they could significantly boost the plaque-clearing activity of these astrocytes.

To test this idea, the scientists observed mice that were already experiencing memory problems. When they used this targeted approach to raise Sox9 levels, the mice showed a noticeable reduction in plaque buildup. Even more importantly, the treatment preserved their memory and cognitive function over time.

Why it matters.

This discovery suggests an exciting shift in how we might treat Alzheimer's disease in the future. Rather than relying solely on external drugs to scrub the brain, future therapies could focus on empowering a patient's own cellular machinery to do the heavy lifting. If successful, this native cleanup process could offer a powerful new way to halt cognitive decline.

Despite the promise, patients and families should view these findings with cautious optimism. The research is still in an early preclinical phase and has only been tested in mouse models. Scientists have not yet established whether this method will be safe or effective in humans. It will take years of rigorous clinical trials before a treatment like this could become available, but it gives the medical industry a brilliant new target for drug development.

From the source

The story in numbers.

Protein target identified (Sox9)
1
Human subjects (early-stage mouse study)
0
Keep the context

Follow the evidence.

This AI-assisted summary is a starting point. Read the original reporting for its methods, scope, and limitations.

Your next discovery.

Keep exploring ↗
Drug Development

A $122M boost for a fast, inside-the-body approach to cell therapy

Create Medicines recently secured $122 million to advance a new class of treatments for cancer and autoimmune diseases. They specialize in CAR-T cell therapy, a treatment that engineers the immune system to fight disease. But instead of the traditional method of removing cells from a patient to alter them in a lab, Create Medicines is developing therapies that work entirely inside the body, a process known as "in vivo" treatment. To achieve this, the therapy uses tiny fat bubbles called lipid nanoparticles to deliver messenger RNA, or mRNA, into the patient. Think of mRNA as a set of biological instructions. Once delivered, these instructions directly teach the patient's existing immune cells, including T cells, natural killer cells, and myeloid cells, to reprogram themselves into disease fighters. The startup has already dosed more than 50 patients, giving it the largest clinical dataset in the in vivo field. They recently began an early-stage clinical trial for an experimental therapy designed to attack solid tumors that carry a specific protein called HER2. Alongside this cancer research, the company is testing other treatments that target proteins called CD19 and BCMA to help patients with autoimmune conditions.

BioPharma Dive1 min read
Drug Development

Supreme Court Protects Access to Common Abortion Pill

The United States Supreme Court has decided to preserve access to mifepristone, a medication used in the most common method of abortion. By rejecting recent restrictions proposed by lower courts, the Supreme Court has ensured that patients can still obtain this widely used drug while an ongoing lawsuit continues to make its way through the legal system. Under this current legal order, patients do not need an in-person visit with a doctor to get the medication. Instead, they are permitted to continue receiving mifepristone directly from pharmacies or through the mail. This ruling maintains the existing distribution methods, meaning that access is expected to remain uninterrupted at least into the following year as further legal proceedings unfold.

STAT News1 min read
Drug Development

Living Implants: Engineered Bacteria Trapped in Gel Fight Infections

What if a medical implant could sense an infection and fight it off automatically? Researchers have created exactly that with a new technology called an "implantable living material." To build it, scientists used a specialized, water-based gel known as a polyvinyl alcohol hydrogel. This material acts as a tiny, flexible fortress. It is uniquely stiff and tough, designed to hold genetically engineered bacteria safely inside for up to six months without them escaping into the surrounding tissue. Inside this protective gel, the researchers trapped a modified version of E. coli bacteria to act as molecular guards. These engineered microbes are programmed to detect chemical signals given off by Pseudomonas aeruginosa, a dangerous pathogen that frequently causes infections around artificial joints. When the trapped bacteria sense the invader, they trigger a targeted self-destruct mechanism. This intentional cellular explosion releases a powerful antibacterial protein that easily passes through the microscopic pores of the gel to kill the infection outside. The research team tested this system in mice with artificial joint infections. Over a three-day treatment period, the living implant significantly reduced the amount of infectious bacteria compared to non-therapeutic controls. By keeping the helpful microbes physically contained while allowing their medicine to flow out, the researchers have found a clever way to turn living cells into localized drug factories.

GEN2 min read

A little science goes a long way.

Clear, thoughtful biotech briefings. In your inbox three times a week.

Stay curious. Subscribe free ↗
Activating support cells helps the brain clear Alzheimer's in mice — Daily Strand